Skip to Content

MainStay Epoch International Choice Inv ICELX

Medalist Rating as of | See New York Life Investment Hub
  • NAV / 1-Day Return 39.15  /  +0.18 %
  • Total Assets 216.5 Mil
  • Adj. Expense Ratio
    1.510%
  • Expense Ratio 1.510%
  • Distribution Fee Level High
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.12%
  • Turnover 34%

USD | NAV as of Apr 17, 2024 | 1-Day Return as of Apr 17, 2024, 10:05 PM GMT+0

Morningstar’s Analysis ICELX

Will ICELX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

MainStay Epoch International Choice Inv's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ICELX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 40.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

AstraZeneca PLC ADR

5.25 11.9 Mil
Healthcare

Lloyds Banking Group PLC

4.39 10.0 Mil
Financial Services

Coca-Cola Europacific Partners PLC

4.24 9.6 Mil
Consumer Defensive

Keyence Corp

4.18 9.5 Mil
Technology

Asahi Group Holdings Ltd

3.96 9.0 Mil
Consumer Defensive

Sony Group Corp

3.93 8.9 Mil
Technology

Linde PLC

3.77 8.6 Mil
Basic Materials

Compass Group PLC

3.62 8.2 Mil
Consumer Cyclical

Airbus SE

3.48 7.9 Mil
Industrials

NN Group NV

3.48 7.9 Mil
Financial Services